| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients
|
Breccia, Massimo
|
|
2015
|
39 |
10 |
p. 1055-1059
5 p.
|
artikel
|
| 2 |
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
|
Laurenti, Luca
|
|
2015
|
39 |
10 |
p. 1066-1070
5 p.
|
artikel
|
| 3 |
Bone marrow niche in the myelodysplastic syndromes
|
Cogle, Christopher R.
|
|
2015
|
39 |
10 |
p. 1020-1027
8 p.
|
artikel
|
| 4 |
DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia
|
Zhang, Ying-ying
|
|
2015
|
39 |
10 |
p. 1041-1047
7 p.
|
artikel
|
| 5 |
Does the concept of lower-risk myelodysplastic syndrome need to be revisited?
|
Falantes, Jose F.
|
|
2015
|
39 |
10 |
p. 1003-1005
3 p.
|
artikel
|
| 6 |
Dynamics of ceramide generation and metabolism in response to fenretinide – Diversity within and among leukemia
|
Morad, Samy A.F.
|
|
2015
|
39 |
10 |
p. 1071-1078
8 p.
|
artikel
|
| 7 |
Editorial board and publication information
|
|
|
2015
|
39 |
10 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects
|
Azimi, Fatemeh
|
|
2015
|
39 |
10 |
p. 1048-1054
7 p.
|
artikel
|
| 9 |
Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS
|
Ganster, Christina
|
|
2015
|
39 |
10 |
p. 1079-1087
9 p.
|
artikel
|
| 10 |
MRP1 and P-glycoprotein expression assays would be useful in the additional detection of treatment non-responders in CML patients without ABL1 mutation
|
Park, Sang Hyuk
|
|
2015
|
39 |
10 |
p. 1109-1116
8 p.
|
artikel
|
| 11 |
Prior cytopenia predicts worse clinical outcome in acute myeloid leukemia
|
Huck, Amelia
|
|
2015
|
39 |
10 |
p. 1034-1040
7 p.
|
artikel
|
| 12 |
Secular trends and predictors of mortality in acute lymphoblastic leukemia for children of low socioeconomic level in Northeast Brazil
|
Viana, Simone Santana
|
|
2015
|
39 |
10 |
p. 1060-1065
6 p.
|
artikel
|
| 13 |
Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway
|
Wang, Wei-Zhang
|
|
2015
|
39 |
10 |
p. 1117-1124
8 p.
|
artikel
|
| 14 |
Synergy of two human endogenous retroviruses in multiple myeloma
|
Schmidt, Kathrine L.M.
|
|
2015
|
39 |
10 |
p. 1125-1128
4 p.
|
artikel
|
| 15 |
TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood
|
Coutinho, Diego F.
|
|
2015
|
39 |
10 |
p. 1103-1108
6 p.
|
artikel
|
| 16 |
The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K
|
Maksimovic-Ivanic, Danijela
|
|
2015
|
39 |
10 |
p. 1088-1095
8 p.
|
artikel
|
| 17 |
Toxicity of doxorubicin-transferrin conjugate is connected to the modulation of Wnt/β-catenin pathway in human leukemia cells
|
Szwed, Marzena
|
|
2015
|
39 |
10 |
p. 1096-1102
7 p.
|
artikel
|
| 18 |
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome – Emphasis on optimized dosing schedules and new formulations
|
Nolte, Florian
|
|
2015
|
39 |
10 |
p. 1028-1033
6 p.
|
artikel
|
| 19 |
Vaccination strategies in lymphoproliferative disorders: Failures and successes
|
Allegra, A.
|
|
2015
|
39 |
10 |
p. 1006-1019
14 p.
|
artikel
|
Tijdschrift beschrijving